Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794].
Saved in:
| Title: | Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794]. |
|---|---|
| Authors: | Hoffmann K (AUTHOR), Glimm H (AUTHOR), Radeleff B (AUTHOR), Richter G (AUTHOR), Heining C (AUTHOR), Schenkel I (AUTHOR), Zahlten-Hinguranage A (AUTHOR), Schirrmacher P (AUTHOR), Schmidt J (AUTHOR), Büchler MW (AUTHOR), Jaeger D (AUTHOR), von Kalle C (AUTHOR), Schemmer P (AUTHOR), Hoffmann, K1 (AUTHOR), Glimm, H (AUTHOR), Radeleff, B (AUTHOR), Richter, G (AUTHOR), Heining, C (AUTHOR), Schenkel, I (AUTHOR), Zahlten-Hinguranage, A (AUTHOR) |
| Source: | BMC Cancer. 2008, Vol. 8, p349-349. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 105524092 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794]. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Hoffmann+K%22">Hoffmann K</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Glimm+H%22">Glimm H</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Radeleff+B%22">Radeleff B</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Richter+G%22">Richter G</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Heining+C%22">Heining C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schenkel+I%22">Schenkel I</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zahlten-Hinguranage+A%22">Zahlten-Hinguranage A</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schirrmacher+P%22">Schirrmacher P</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schmidt+J%22">Schmidt J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Büchler+MW%22">Büchler MW</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jaeger+D%22">Jaeger D</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22von+Kalle+C%22">von Kalle C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schemmer+P%22">Schemmer P</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hoffmann%2C+K%22">Hoffmann, K</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Glimm%2C+H%22">Glimm, H</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Radeleff%2C+B%22">Radeleff, B</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Richter%2C+G%22">Richter, G</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Heining%2C+C%22">Heining, C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schenkel%2C+I%22">Schenkel, I</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zahlten-Hinguranage%2C+A%22">Zahlten-Hinguranage, A</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 2008, Vol. 8, p349-349. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=105524092 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/1471-2407-8-349 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: 349 Titles: – TitleFull: Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation - HeiLivCa [ISRCTN24081794]. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hoffmann K – PersonEntity: Name: NameFull: Glimm H – PersonEntity: Name: NameFull: Radeleff B – PersonEntity: Name: NameFull: Richter G – PersonEntity: Name: NameFull: Heining C – PersonEntity: Name: NameFull: Schenkel I – PersonEntity: Name: NameFull: Zahlten-Hinguranage A – PersonEntity: Name: NameFull: Schirrmacher P – PersonEntity: Name: NameFull: Schmidt J – PersonEntity: Name: NameFull: Büchler MW – PersonEntity: Name: NameFull: Jaeger D – PersonEntity: Name: NameFull: von Kalle C – PersonEntity: Name: NameFull: Schemmer P – PersonEntity: Name: NameFull: Hoffmann, K – PersonEntity: Name: NameFull: Glimm, H – PersonEntity: Name: NameFull: Radeleff, B – PersonEntity: Name: NameFull: Richter, G – PersonEntity: Name: NameFull: Heining, C – PersonEntity: Name: NameFull: Schenkel, I – PersonEntity: Name: NameFull: Zahlten-Hinguranage, A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2008 Type: published Y: 2008 Identifiers: – Type: issn-print Value: 14712407 Numbering: – Type: volume Value: 8 Titles: – TitleFull: BMC Cancer Type: main |
| ResultId | 1 |
